The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.
Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Abstract
We compared the effect of abrupt discontinuation of therapeutic doses of short half-life and long half-life benzodiazepines in 57 benzodiazepine-dependent patients (daily use, greater than 1 year). Despite the use of a mean daily dose of 14.1 mg of diazepam equivalents, there were notable residual symptoms of anxiety and depression present at intake (Hamilton Rating Scale for Anxiety score, 17.0; Hamilton Rating Scale for Depression score, 14.0). Benzodiazepine intake was stabilized for 3 weeks before double-blind assignment to placebo (n = 47), or continued benzodiazepine use (n = 10). Clinical assessments were performed daily, including benzodiazepine plasma levels. Depending on the outcome criteria used, anywhere from 58% to 100% of patients were judged to have experienced a withdrawal reaction, with a peak severity at 2 days for short half-life and 4 to 7 days for long half-life benzodiazepines. Relapse onto benzodiazepines occurred in 27% of patients who were receiving long half-life benzodiazepines and in 57% of patients who were receiving short half-life benzodiazepines. Baseline predictors of relapse were nonpanic diagnoses, a higher benzodiazepine dose, and a higher Eysenck neuroticism score. A short half-life and higher daily doses were associated with greater withdrawal severity, as were personality traits, such as dependency and neuroticism, less education and higher baseline levels of anxious and depressive symptoms. Patients who were able to remain free of benzodiazepines for at least 5 weeks obtained lower levels of anxiety than before benzodiazepine discontinuation. These results provide a detailed picture of the symptoms, time course, and multidimensional determinants of the benzodiazepine withdrawal syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The proportion of patients who experienced acute withdrawal in our findings ranged from approximately 44% [52] to 100% [61,62].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [62]
In the citing paper
“Acute withdrawal symptoms occurred in up to 100% of participants from studies found in this scoping review [52,61,62], but prolonged symptoms were less frequently reported, occurring in approximately 30% of benzodiazepine patients [17,54,69].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [62]
In the citing paper
“but it is the psychopathological variables [86,87,88,89,90,91] (e.g., psychological suffering, anxiety or insomnia) which best predict relapse rates in withdrawal programs.”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [91]
In the citing paper
“By encouraging the patient to take an active role, this goal-oriented approach increases compliance with the withdrawal program and reduces the risk of early relapse [38,44,86,87,91,116].”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [91]
In the citing paper
“However, results from other studies have suggested that, compared with long-t 1 ⁄ 2 BZDs, BZDs with short t 1 ⁄ 2 are associated with faster onset of withdrawal symptoms or more severe withdrawal symptoms when BZD therapy is stopped abruptly (211, 212).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [211]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Self-citationPredicting Response to Alcohol and Drug Abuse Treatments: Role of Psychiatric Severity
McLellan, A. T. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010030004 · Cited by 805
Rickels, K. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290060008 · Cited by 384
Self-citationPrognostic Significance of Psychopathology in Treated Opiate Addicts: A 2.5-Year Follow-up Study
Rounsaville, B. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800080025004 · Cited by 372
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
The symptoms of major depressive illness
(1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.1 · Cited by 357
Cited by
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Metadata
- Authors
- Rickels, K.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Rickels, Karl
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1990-10-01
- Volume
- 47
- Issue
- 10
- Pages
- 899
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1998935547
- Cited by
- 332
- References
- 35
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 15 · 2021: 6 · 2020: 9 · 2019: 9 · 2018: 16 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 10
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-08957, MH 34223)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine withdrawal syndrome, benzodiazepine dependence, benzodiazepine discontinuation, relapse, withdrawal severity, predictors of relapse, neuroticism, anxiety, depression
- MeSH terms
- Ambulatory Care, Anxiety Disorders, Benzodiazepines, Dependent Personality Disorder, Depressive Disorder, Diazepam, Double-Blind Method, Factor Analysis, Statistical, Half-Life, Humans, Outcome and Process Assessment, Health Care, Panic, Personality Inventory, Placebos, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation. https://app.cochat.ai/papers/10.1001/archpsyc.1990.01810220015002
- The paper
- Rickels, K. (1990). Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1990.01810220015002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.